Sanofi · 2 days ago
Senior Director, Access Strategy Established Products
Cambridge, MA
Full-time
Onsite
Director/Executive
10+ years expSanofi is an innovative global healthcare company with a focus on immunology and other medical innovations. The Sr Director, Access Strategy Established Products will lead a team responsible for developing and implementing market access strategies for established products, engaging with various internal and external stakeholders to optimize product positioning and pricing.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Partner effectively with support functions, Global Market Access and US teams to execute on MAx core deliverables (ex. specific market access or other tools)
Represent the access customer perspective within cross-functional, cross-regional commercialization teams including Brand, USMA, HEVA/RWE, Market Access Shared Services, Trade, Finance, Communications, Policy/Advocacy, and Public Affairs thereby optimizing the lifecycle of transplant products
Partner with relevant departments (as listed above) to influence the market assessment, product positioning, and target product profile by providing strategic input regarding market access, reimbursement, and pricing information throughout the product lifecycle
Participate in account discussions, as necessary, to communicate brand value, strategies, and market dynamics as they impact the product
As a part of the broader global market access community, work closely with access professionals across the world ensuring consistent feedback and optimization of Global Value and Access deliverables including launch preparation, negotiations training, and contracting (including value-based and outcomes-based frameworks)
Develop market access strategies for future indications including generation of pricing recommendation, value proposition and messages, and detailed forecast assumptions, support strategies within depth market research, and environmental data & analogs as appropriate
Partner closely with marketing on the assessment of business development/divestiture opportunities
Monitor the marketplace for market access challenges, trends, threats & opportunities
Partner closely with market access strategy colleagues within BU and across the organization to share best practices, customer insights and emerging trends
Qualification
Required
BA/BS and 10+ years' relevant professional experience including market access, health economics, pricing & reimbursement
10+ years' experience at local and/or international level w/ knowledge of US and Global market access & payer environment
Knowledge of disease market access desirable, but other backgrounds are welcomed
Preferred
Proven track record of leading within a matrix environment to reach business objectives
Demonstrated ability to take on highly complex business problems, recommend strategic and tactical solutions in a simple and straightforward manner
Exhibits outstanding written and oral communication skills, including the ability to effectively write and deliver presentations to professionals at all levels within Sanofi
Demonstrated relationship building and team management at all levels of the organization and across geographies
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
2026-01-07
vcnewsdaily.com
2026-01-07
Pharma Letter
2026-01-07
Company data provided by crunchbase